Elcheva et al. reported that inhibition of IGF2BP1 reduced the tumorigenicity of leukemia cells and promoted leukemia cell death and differentiation by regulating HOXB4, MYB, and ALDH1A130. Here, IGF2BP1 is linked to leukemia.